Momenta Pharmaceuticals, Inc.
MNTA
MNTA was delisted on the 30th of September, 2020.
0 hedge funds and large institutions have $0 invested in Momenta Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 211 closing their positions.
100% less funds holding
Funds holding: 211 → 0 (-211)
100% less funds holding in top 10
Funds holding in top 10: 16 → 0 (-16)
100% less capital invested
Capital invested by funds: $5.44B → $0 (-$5.44B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 211
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.01B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$685M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$622M |
| 4 |
HI
HBK Investments
Dallas,
Texas
|
-$257M |
| 5 |
State Street
Boston,
Massachusetts
|
-$238M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
QCG
201
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$6K | -119 | Closed |
|
|
GAM
202
Gemmer Asset Management
Walnut Creek,
California
| – | -$5K | -92 | Closed |
|
|
BCA
203
Berman Capital Advisors
Atlanta,
Georgia
| – | -$3K | -65 | Closed |
|
204
Fifth Third Bancorp
Cincinnati,
Ohio
| – | -$3K | -50 | Closed |
|
|
BWA
205
BDO Wealth Advisors
Jacksonville,
Florida
| – | -$2K | -41 | Closed |
|
|
MAM
206
Meeder Asset Management
Dublin,
Ohio
| – | -$2K | -36 | Closed |
|
|
PFGIA
207
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
| – | -$2K | -30 | Closed |
|
208
AssetMark Inc
Concord,
California
| – | -$1K | -24 | Closed |
|
|
ABC
209
Associated Banc-Corp
Green Bay,
Wisconsin
| – | -$1K | -20 | Closed |
|
|
IA
210
IFP Advisors
Tampa,
Florida
| – | -$1K | -14 | Closed |
|
MNTA Hedge Fund Activity: Q4 2020 in Review
0 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q4 2020, worth a combined $0 — down 100% from $5.44B a quarter earlier.
Sellers outnumbered buyers: 211 funds closed out of MNTA and 0 opened new positions — a net loss of 211 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $1.01B sold.
- 0 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q4 2020, down from 211 in Q3 2020.
- Funds reported $0 of Momenta Pharmaceuticals, Inc. stock for Q4 2020, down 100% quarter-over-quarter.
- 0 funds opened new Momenta Pharmaceuticals, Inc. positions in Q4 2020 and 211 closed out, a net change of -211 holders.
- The largest Momenta Pharmaceuticals, Inc. seller in Q4 2020 was BlackRock, an estimated $1.01B sold.
Based on aggregated 13F filings for Q4 2020.